REHOVOT, Israel, Dec. 18, 2019 /PRNewswire/ -- Raziel Therapeutics a clinical-stage pharmaceutical company announces a $22 million Series C preferred stock financing led by Pontifax, with the participation of existing investors Dr. Shmuel Cabilly and Docor International plus new...